Treatment of cochlear tinnitus with transtympanic infusion of 4% lidocaine into the tympanic cavity

Sakata, H.; Kojima, Y.; Koyama, S.; Furuya, N.; Sakata, E.

International Tinnitus Journal 7(1): 46-50

2001


ISSN/ISBN: 0946-5448
PMID: 14964956
Document Number: 10269
Tinnitus is an otological symptom that is encountered often, yet its treatment is difficult. If tinnitus is of cochlear origin, a reasonable assumption is that a total depression of the cochlear function will abolish cochlear tinnitus. To achieve this depression, transtympanic infusion of a local anesthetic (4% lidocaine) to anesthetize the inner ear was conducted in a patient suffering from tinnitus. Transtympanic infusion of 4% lidocaine was performed as a treatment for cochlear tinnitus, and its efficacy was investigated. The overall efficacy rate for the 292 patients with 369 affected ears was 81%. In the investigation of the treatment results in cases of different underlying ear diseases, the efficacy rate was high for tinnitus accompanying sudden deafness and labyrinthine vertigo. However, vestibular symptoms, such as vertigo and nausea, developed after lidocaine infusion. No permanent side effects were noted. Lidocaine infusion is thought to be a useful treatment option for tinnitus and should be considered before surgical treatment. Inner ear anesthesia into the tympanic cavity has been carried out in patients who had cochlear tinnitus and in whom conservative methods of therapy, such as oral medication, had proved unsuccessful. This treatment method is useful as a local therapy for cochlear tinnitus.

Document emailed within 1 workday
Secure & encrypted payments

Treatment of cochlear tinnitus with transtympanic infusion of 4% lidocaine into the tympanic cavity